<?xml version="1.0" encoding="ISO-8859-1" ?>
		<rss version="2.0">
		<channel>
		<title><![CDATA[Societa' Italiana di Cardiologia Invasiva]]></title>
		<link>http://www.gise.it</link>
		<description>Feed Societa' Italiana di Cardiologia Invasiva</description>
		<language>it</language>
		<generator><![CDATA[Arkè2 - Powered by Connexxa]]></generator>
		<image>
		<url>http://www.gise.it/images/logo.jpg</url>
		<title>www.gise.it</title>
		<link>http://www.gise.it</link>
		<description>Feed Societa' Italiana di Cardiologia Invasiva</description>
		</image><item>	
			<title><![CDATA[GISE EuroPCR 2012]]></title>
			<link>http://www.gise.it/news/576/gise_europcr_2012</link>				
			<description><![CDATA[ GISE- EuroPCR 2012
Parigi, 15-18 maggio 2012
 
Sessione SICI-GISE: Venerdì 18 maggio 2012, ore 10.30-11.50
 (Level 2 &ndash; Room 252A)
&ldquo;How should I treat? Tips and tricks for complex TAVI procedures&rdquo;
Chairpersons:Corrado Tamburino, R. Kornowski
Panellists: L. Testa, A. Elami
 
 
 
 
Get Together 
 
Vi aspettiamo
Giovedì 17 maggio dalle 18.00 alle 19.00
 
Stand GISE
Level 3  Hall Bordeaux &lsquo;Scientific Village&rsquo; stand nr B06
 
 

Segreteria Gise gisemail@tin.it
...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 17 Apr 2012 10:50:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/576/gise_europcr_2012</guid>		
	</item><item>	
			<title><![CDATA[Clinical interventional Forum - Desenzano - 21 Aprile 2012 ]]></title>
			<link>http://www.gise.it/news/574/clinical_interventional_forum_desen</link>				
			<description><![CDATA[
]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 11 Apr 2012 11:30:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/574/clinical_interventional_forum_desen</guid>		
	</item><item>	
			<title><![CDATA[Gise Emilia Romagna - Triveneto, 4 Maggio 2012]]></title>
			<link>http://www.gise.it/news/573/gise_emilia_romagna_triveneto_4_mag</link>				
			<description><![CDATA[]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 23 Mar 2012 15:13:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/573/gise_emilia_romagna_triveneto_4_mag</guid>		
	</item><item>	
			<title><![CDATA[ANMCO - Genova - 5 Maggio 2012]]></title>
			<link>http://www.gise.it/news/572/anmco_genova_5_maggio_2012</link>				
			<description><![CDATA[]]></description>
			<author>www.gise.it</author>
			<pubDate>Sun, 05 Feb 2012 19:58:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/572/anmco_genova_5_maggio_2012</guid>		
	</item><item>	
			<title><![CDATA[Genova - 3/5 Ottobre 2012]]></title>
			<link>http://www.gise.it/news/571/genova_3_5_ottobre_2012</link>				
			<description><![CDATA[Per maggiori informazioni clicca qui]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 03 Feb 2012 12:27:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/571/genova_3_5_ottobre_2012</guid>		
	</item><item>	
			<title><![CDATA[Gise Campania - 14 Aprile 2012]]></title>
			<link>http://www.gise.it/news/570/gise_campania_14_aprile_2012</link>				
			<description><![CDATA[]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 03 Feb 2012 12:06:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/570/gise_campania_14_aprile_2012</guid>		
	</item><item>	
			<title><![CDATA[Scarica i 4 numeri del GISE NEWS 2011]]></title>
			<link>http://www.gise.it/news/562/scarica_i_4_numeri_del_gise_news_20</link>				
			<description><![CDATA[ 

	In allegato si possono scaricare i numeri del Gise News 2011 presentati durante l&#39;ultimo Congresso della Società Italiana di Cardiologia Invasiva. 
	 

	Direttore Responsabile

	Davide Capodanno
	
	Comitato di Redazione
	Marco Barbanti
	Mario Bollati
	Piera Capranzano
	Fabrizio D&rsquo;Ascenzo
	Beatrice Magro
	Alberto Polimeni
	Giovanna Sarno
	Paolo Sbarzaglia
	
	Layout
	Beatrice Paolacci
	 
...]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 04 Nov 2011 12:01:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/562/scarica_i_4_numeri_del_gise_news_20</guid>		
	</item><item>	
			<title><![CDATA[Censimento Healthy Cath Lab: online il questionario]]></title>
			<link>http://www.gise.it/news/554/censimento_healthy_cath_lab_online_</link>				
			<description><![CDATA[
	
Disponibile online la web survey &#39;HCL. - Healthy Cath Lab&#39;. Il questionario è disponibile all&#39;indirizzo:

https://cesena.ifc.cnr.it/hcl/index.html

Per ulteriori informazioni sullo studio HCL, leggi qui

]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 30 Sep 2011 21:14:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/554/censimento_healthy_cath_lab_online_</guid>		
	</item><item>	
			<title><![CDATA[Congresso Nazionale SISS - Ictus: Quale futuro? - L'Aquila 27/29 Settembre 2012 ]]></title>
			<link>http://www.gise.it/news/569/congresso_nazionale_siss_ictus_qual</link>				
			<description><![CDATA[
]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 06 Sep 2011 14:38:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/569/congresso_nazionale_siss_ictus_qual</guid>		
	</item><item>	
			<title><![CDATA[NSTE/ACS - ESC Guidelines 2011]]></title>
			<link>http://www.gise.it/news/549/nste_acs_esc_guidelines_2011</link>				
			<description><![CDATA[]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 31 Aug 2011 18:10:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/549/nste_acs_esc_guidelines_2011</guid>		
	</item><item>	
			<title><![CDATA[Clinical Outcomes Using a New Crossover Balloon Occlusion Technique for Percutaneous Closure After Transfemoral Aortic Valve Implantation]]></title>
			<link>http://www.gise.it/news/548/clinical_outcomes_using_a_new_cross</link>				
			<description><![CDATA[Objectives: This study sought to evaluate the technical success and clinical outcomes of an adjunctive crossover balloon occlusion technique (CBOT) combined with the 10-F Prostar percutaneous closure device (PCD) on the incidence of vascular and bleeding complications in patients after transfemoral transcatheter aortic valve implantation (TAVI). 

	Background: Vascular closure following large-vessel access has most commonly been performed using a surgical cut-down and repair procedure. 

	Me...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 23 Aug 2011 14:45:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/548/clinical_outcomes_using_a_new_cross</guid>		
	</item><item>	
			<title><![CDATA[Percutaneous Coronary Intervention in Native Arteries Versus Bypass Grafts in Prior Coronary Artery Bypass Grafting Patients]]></title>
			<link>http://www.gise.it/news/547/percutaneous_coronary_intervention_</link>				
			<description><![CDATA[Objectives: This study examined a large registry to determine the frequency, predictors, and outcomes of native coronary artery versus bypass graft percutaneous coronary intervention (PCI) in patients with prior coronary artery bypass graft surgery (CABG). 

	Background: The PCI target vessel and corresponding outcomes in prior CABG patients are poorly studied. 

	Methods: We analyzed the frequency and factors associated with native versus bypass graft PCI in prior CABG patients undergoing P...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 23 Aug 2011 14:43:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/547/percutaneous_coronary_intervention_</guid>		
	</item><item>	
			<title><![CDATA[Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease]]></title>
			<link>http://www.gise.it/news/546/randomized_trial_of_stents_versus_b</link>				
			<description><![CDATA[
	
		Background
	
		Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis, although coronary-artery bypass grafting (CABG) has been considered to be the treatment of choice.


	 

	
		Methods
	
		We randomly assigned patients with unprotected left main coronary artery stenosis to undergo CABG (300 patients) or PCI with sirolimus-eluting stents (300 patients). Using a wide margin for noninferiority, we compared the groups...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 23 Aug 2011 14:40:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/546/randomized_trial_of_stents_versus_b</guid>		
	</item><item>	
			<title><![CDATA[Healthy Cath Lab al GISE 2011: un progetto a tutela della tua, della nostra salute]]></title>
			<link>http://www.gise.it/news/545/healthy_cath_lab_al_gise_2011_un_pr</link>				
			<description><![CDATA[Il numero di procedure interventistiche cardiovascolari guidate dalla fluoroscopia è aumentato sensibilmente nel corso degli ultimi 20 anni, insieme alla consapevolezza del rischio professionale correlato alle radiazioni. I cardiologi interventisti rappresentano in assoluto le figure sanitarie più esposte, ma anche i tecnici e gli infermieri che lavorano in emodinamica non sono certo immuni da rischi per la loro salute. Le radiazioni non causano solo un incremento del numero di neoplasie, ma anc...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 23 Aug 2011 13:43:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/545/healthy_cath_lab_al_gise_2011_un_pr</guid>		
	</item><item>	
			<title><![CDATA[Parte la prima regione del programma Stent for life in Italia]]></title>
			<link>http://www.gise.it/news/540/parte_la_prima_regione_del_programm</link>				
			<description><![CDATA[
	- Londra 1 luglio. TREATMENT OF ACUTE MYOCARDIAL INFARCTION IN EUROPE: REVIEW OF CURRENT MODELS AND PROPOSAL OF OPTIMAL COMMON STANDARDS. 

	Presso l&rsquo;Ambasciata italiana a Londra, in presenza del Sen. Guido Viceconte sottosegretario al Ministero della Ricerca Scientifica, il 1 di luglio, le maggiori società scientifiche europee, presenteranno per la prima volta alla Commissione Europea nella persona dell&rsquo; On. Antonio Tajani vice presidente della Commissione, gli standard ottimal...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 29 Jun 2011 17:14:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/540/parte_la_prima_regione_del_programm</guid>		
	</item><item>	
			<title><![CDATA[Myocardial Infarction After Carotid Stenting and Endarterectomy]]></title>
			<link>http://www.gise.it/news/539/myocardial_infarction_after_carotid</link>				
			<description><![CDATA[Circulation. 2011;123:2571-2578
Published online before print May 23, 2011, doi: 10.1161/CIRCULATIONAHA.110.008250

Myocardial Infarction After Carotid Stenting and Endarterectomy

Results From the Carotid Revascularization Endarterectomy Versus Stenting Trial

Joseph L. Blackshear, MD; Donald E. Cutlip, MD; Gary S. Roubin, MD; Michael D. Hill, MD; Pierre P. Leimgruber, MD; Richard J. Begg, MD; David J. Cohen, MD; John F. Eidt, MD; Craig R. Narins, MD; Ronald J. Prineas, MD; Stephen P. Glasser, ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 08 Jun 2011 11:15:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/539/myocardial_infarction_after_carotid</guid>		
	</item><item>	
			<title><![CDATA[Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease]]></title>
			<link>http://www.gise.it/news/528/randomized_trial_of_stents_versus_b</link>				
			<description><![CDATA[
	
		Background
	
		Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis, although coronary-artery bypass grafting (CABG) has been considered to be the treatment of choice.
	
		Full Text of Background...


	 

	
		Methods
	
		We randomly assigned patients with unprotected left main coronary artery stenosis to undergo CABG (300 patients) or PCI with sirolimus-eluting stents (300 patients). Using a wide margin for nonin...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 14 Apr 2011 14:54:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/528/randomized_trial_of_stents_versus_b</guid>		
	</item><item>	
			<title><![CDATA[Percutaneous Repair or Surgery for Mitral Regurgitation]]></title>
			<link>http://www.gise.it/news/527/percutaneous_repair_or_surgery_for_</link>				
			<description><![CDATA[
	
		Background
	
		Mitral-valve repair can be accomplished with an investigational procedure that involves the percutaneous implantation of a clip that grasps and approximates the edges of the mitral leaflets at the origin of the regurgitant jet.


	 

	
		Methods
	
		We randomly assigned 279 patients with moderately severe or severe (grade 3+ or 4+) mitral regurgitation in a 2:1 ratio to undergo either percutaneous repair or conventional surgery for repair or replacement of the mit...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 14 Apr 2011 14:50:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/527/percutaneous_repair_or_surgery_for_</guid>		
	</item><item>	
			<title><![CDATA[Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension]]></title>
			<link>http://www.gise.it/news/523/management_of_massive_and_submassiv</link>				
			<description><![CDATA[
	
	Venous thromboembolism (VTE) is responsible for the
	hospitalization of 250 000 Americans annually and
	represents a significant risk for morbidity and mortality.1
	Despite the publication of evidence-based clinical practice
	guidelines to aid in the management of VTE in its acute and
	chronic forms,2,3 the clinician is frequently confronted with
	manifestations of VTE for which data are sparse and optimal
	management is unclear. In particular, the optimal use of
	advanced therapies for acut...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 31 Mar 2011 12:32:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/523/management_of_massive_and_submassiv</guid>		
	</item><item>	
			<title><![CDATA[Guidelines For UA/NSTEMI AHA 2011]]></title>
			<link>http://www.gise.it/news/522/guidelines_for_ua_nstemi_aha_2011</link>				
			<description><![CDATA[
	Introduction
	
	Organization of Committee and
	Evidence Review (UPDATED)
	For new or updated text, view the 2011 Focused Update.
	Text supporting unchanged recommendations has not been
	updated.
	The ACC/AHA Task Force on Practice Guidelines was
	formed to make recommendations regarding the diagnosis
	and treatment of patients with known or suspected cardiovas-
	cular disease (CVD). Coronary artery disease (CAD) is the
	leading cause of death in the United States. Unstable angina
	(UA) and the...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 31 Mar 2011 12:24:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/522/guidelines_for_ua_nstemi_aha_2011</guid>		
	</item><item>	
			<title><![CDATA[Il Giornale Italiano di Cardiologia Invasiva ed il sito www.gise.it su iPad]]></title>
			<link>http://www.gise.it/news/519/il_giornale_italiano_di_cardiologia</link>				
			<description><![CDATA["Il Giornale Italiano di Cardiologia Invasiva" ed il sito &ldquo;www.gise.it&rdquo; su iPad
 

	

	Da venerdì chi possiede un iPad potrà scaricare gratuitamente da Apple Store l&#39;applicazione per leggere Il Giornale Italiano di Cardiologia Invasiva  e consultare le precedenti edizioni del giornale. Basterà cliccare l&#39;icona "Gise" per aprire l&#39;applicazione, il cui utilizzo è facile e intuitivo.

	 
	Vi spieghiamo come funziona l&#39;applicazione. Vai su Apple Store e scarica gratuitame...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 08 Mar 2011 13:07:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/519/il_giornale_italiano_di_cardiologia</guid>		
	</item><item>	
			<title><![CDATA[Trends in Coronary Revascularization in the United States From 2001 to 2009]]></title>
			<link>http://www.gise.it/news/512/trends_in_coronary_revascularizatio</link>				
			<description><![CDATA[
	Abstract

	
		Background There is speculation that the volume of percutaneous coronary interventions (PCIs) has been decreasing over the past several years. Published studies of PCI volume have evaluated regional or hospital trends, but few have captured national data. This study describes the use of coronary angiography and revascularization methods in Medicare patients from 2001 to 2009.


	
		Methods and Results This retrospective study used data from the Centers for Medicare & Medicaid Ser...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 09 Feb 2011 10:38:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/512/trends_in_coronary_revascularizatio</guid>		
	</item><item>	
			<title><![CDATA[Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease 2011]]></title>
			<link>http://www.gise.it/news/511/guideline_on_the_management_of_pati</link>				
			<description><![CDATA[ It is essential that the medical profession play a central role in critically evaluating the evidence related to drugs, devices, and procedures for the detection, management, or prevention of disease. Properly applied, rigorous, expert analysis of the available data documenting absolute and relative benefits and risks of these therapies and procedures can improve the effectiveness of care, optimize patient outcomes, and favorably affect the cost of care by focusing resources on the most effecti...]]></description>
			<author>www.gise.it</author>
			<pubDate>Mon, 07 Feb 2011 09:18:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/511/guideline_on_the_management_of_pati</guid>		
	</item><item>	
			<title><![CDATA[Value of Age, Creatinine, and Ejection Fraction (ACEF Score) in Assessing Risk in Patients Undergoing Percutaneous Coronary Interventions in the All-Comers LEADERS Trial]]></title>
			<link>http://www.gise.it/news/508/value_of_age_creatinine_and_ejectio</link>				
			<description><![CDATA[
	Abstract

	Background&mdash;The age, creatinine, and ejection fraction (ACEF) score (age/left ventricular ejection fraction+1 if creatinine >2.0 mg/dL) has been established as an effective predictor of clinical outcomes in patients undergoing elective coronary artery bypass surgery; however, its utility in &ldquo;all-comer&rdquo; patients undergoing percutaneous coronary intervention is yet unexplored.

	Methods and Results&mdash;The ACEF score was calculated for 1208 of the 1707 patients enro...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 19 Jan 2011 12:19:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/508/value_of_age_creatinine_and_ejectio</guid>		
	</item><item>	
			<title><![CDATA[Clinical Referral Patterns for Carotid Artery Stenting Versus Carotid Endarterectomy]]></title>
			<link>http://www.gise.it/news/507/clinical_referral_patterns_for_caro</link>				
			<description><![CDATA[
	Abstract

	Background&mdash;Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are alternative strategies for stroke prevention in patients with atherosclerotic carotid disease. Although randomized clinical trials are the gold standard for assessing the relative benefits of different treatments, observational research is necessary for determining &ldquo;real-world&rdquo; effectiveness. Current recommendations limit the application of CAS to high-risk patients, undermining the abili...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 19 Jan 2011 12:14:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/507/clinical_referral_patterns_for_caro</guid>		
	</item><item>	
			<title><![CDATA[FONDAZIONE GISE: "Scuola di Formazione Superiore di Interventistica Cardiovascolare"]]></title>
			<link>http://www.gise.it/news/505/fondazione_gise_scuola_di_formazion</link>				
			<description><![CDATA[OBBIETTIVI DEL CORSO

Il corso della Scuola di Formazione Permanente GISE si propone di fornire ai partecipanti una
adeguata e aggiornata preparazione teorica e pratica nel campo della interventistica
cardiovascolare, rendendoli capaci di porre corrette indicazioni di trattamento e di eseguire
come primo operatore procedure interventistiche cardiovascolari semplici e complesse. I
candidati dovranno essere inoltre avviati a tecniche avanzate di diagnostica ed interventistica
endovascolare sia di ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 21 Dec 2010 16:47:00 +0100</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/505/fondazione_gise_scuola_di_formazion</guid>		
	</item><item>	
			<title><![CDATA[IL NUOVO VOLTO DEL SITO DELLA SOCIETA' ITALIANA DI CARDIOLOGIA INVASIVA]]></title>
			<link>http://www.gise.it/news/496/il_nuovo_volto_del_sito_della_socie</link>				
			<description><![CDATA[ Messo on-line da pochi giorni. Il sito gise.it si è rinnovato con web 2.0. Web 2.0 non significa un vecchio sito con una nuova grafica, significa invece un nuovo approccio alla tecnologia, un nuovo modo di utilizzare le risorse online.
Il sito ha potenzialità elevate, nuovi spazi (regionali, personale infermieristico e tecnico, informazioni per pazienti e per Medici di Medicina Generale), e modalità di comunicazione innovative.
All&rsquo;interno del sito è possibile visualizzare l&rsquo;intera ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Sat, 23 Oct 2010 10:53:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/496/il_nuovo_volto_del_sito_della_socie</guid>		
	</item><item>	
			<title><![CDATA[Studio osservazionale per la valutazione comparativa di efficacia dei trattamenti TAVI e AVR]]></title>
			<link>http://www.gise.it/news/489/studio_osservazionale_per_la_valuta</link>				
			<description><![CDATA[
	
	 

	La Società Italiana di Cardiologia Invasiva (SICI-GISE), in accordo con la Federazione Italiana di Cardiologia (FIC) e con la Società Italiana di Chirurgia Cardiaca (SICCH), in collaborazione con Agenas, Ministero della Salute, Istituto Superiore di Sanità, Regioni e Agenzie Regionali, con il patrocinio dell&#39;Italian Association of Cardiothoracic Anesthesia (ITACTA) e con il coinvolgimento attivo delle strutture sanitarie che operano nel settore, promuove la realizzazione dello studio...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 14 Oct 2010 19:46:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/489/studio_osservazionale_per_la_valuta</guid>		
	</item><item>	
			<title><![CDATA[Guidelines on myocardial revascularization]]></title>
			<link>http://www.gise.it/news/485/guidelines_on_myocardial_revascular</link>				
			<description><![CDATA[ Introduction
Myocardial revascularization has been an established mainstay in the
treatment of CAD for almost half a century. Coronary artery bypass
grafting (CABG), used in clinical practice since the 1960s, is arguably
the most intensively studied surgical procedure ever undertaken,
while percutaneous coronary intervention (PCI), used for over
three decades, has been subjected to more randomized clinical
trials (RCTs) than any other interventional procedure. PCI was
first introduced in 1977 b...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:37:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/485/guidelines_on_myocardial_revascular</guid>		
	</item><item>	
			<title><![CDATA[Drug-Eluting Versus Bare-Metal Stents in Unprotected Left Main Coronary Artery Stenosis]]></title>
			<link>http://www.gise.it/news/484/drug_eluting_versus_bare_metal_sten</link>				
			<description><![CDATA[ 

	Objectives: We undertook a meta-analysis to assess outcomes for drug-eluting stents (DES) and bare-metal stents (BMS) in percutaneous coronary intervention for unprotected left main coronary artery (ULMCA) stenosis. 

	Background: Uncertainty exists regarding the relative performance of DES versus BMS in percutaneous coronary intervention for unprotected left main coronary stenosis. 

	Methods: Of a total of 838 studies, 44 met inclusion criteria (n = 10,342). The co-primary end points were ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:34:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/484/drug_eluting_versus_bare_metal_sten</guid>		
	</item><item>	
			<title><![CDATA[Prevention and Treatment of Microvascular Obstruction-Related Myocardial Injury and Coronary No-Reflow Following Percutaneous Coronary Intervention]]></title>
			<link>http://www.gise.it/news/483/prevention_and_treatment_of_microva</link>				
			<description><![CDATA[ Microvascular obstruction (MVO) commonly occurs following percutaneous coronary interventions (PCI), may lead to myocardial injury, and is an independent predictor of adverse outcome. Severe MVO may manifest angiographically as reduced flow in the patent upstream epicardial arteries, a situation that is termed "no-reflow." Microvascular obstruction can be broadly categorized according to the duration of myocardial ischemia preceding PCI. In "interventional MVO" (e.g., elective PCI), obstruction...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:33:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/483/prevention_and_treatment_of_microva</guid>		
	</item><item>	
			<title><![CDATA[Outcomes of Percutaneous Coronary Intervention in Intermediate Coronary Artery Disease]]></title>
			<link>http://www.gise.it/news/482/outcomes_of_percutaneous_coronary_i</link>				
			<description><![CDATA[ 

	Objectives: This study sought to evaluate the long-term clinical outcomes of a fractional flow reserve (FFR)&ndash;guided percutaneous coronary intervention (PCI) strategy compared with intravascular ultrasound (IVUS)&ndash;guided PCI for intermediate coronary lesions. 

	Background: Both FFR- and IVUS-guided PCI strategies have been reported to be safe and effective in intermediate coronary lesions. 

	Methods: The study included 167 consecutive patients, with intermediate coronary lesions ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:31:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/482/outcomes_of_percutaneous_coronary_i</guid>		
	</item><item>	
			<title><![CDATA[Clinical and Angiographic Risk Assessment in Patients With Left Main Stem Lesions]]></title>
			<link>http://www.gise.it/news/481/clinical_and_angiographic_risk_asse</link>				
			<description><![CDATA[ Percutaneous coronary intervention of unprotected left main stem lesions has been shown to be a suitable alternative to cardiac surgery in selected patients, emphasizing the need for appropriate risk stratification prior to selection of revascularization modality. Several risk models based on clinical and angiographic variables have been developed to guide patient selection, each of which has significant limitations. This paper reviews contemporary and newly proposed risk models for patients un...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:29:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/481/clinical_and_angiographic_risk_asse</guid>		
	</item><item>	
			<title><![CDATA[Clinical and Angiographic Predictors of Short- and Long-Term Ischemic Events in Acute Coronary Syndromes]]></title>
			<link>http://www.gise.it/news/480/clinical_and_angiographic_predictor</link>				
			<description><![CDATA[ 

	Background&mdash; Contemporary adjunctive pharmacology and revascularization strategies have improved the prognosis of patients with acute coronary syndromes (ACSs). We sought to identify the clinical and angiographic predictors of cardiac ischemic events in patients with ACSs treated with an early invasive strategy. 

	Methods and Results&mdash; Multivariable logistic regression was used to analyze the relation between baseline characteristics and 30-day and 1-year composite ischemia (death...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:26:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/480/clinical_and_angiographic_predictor</guid>		
	</item><item>	
			<title><![CDATA[A Model for Predicting Mortality in Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention]]></title>
			<link>http://www.gise.it/news/479/a_model_for_predicting_mortality_in</link>				
			<description><![CDATA[ 

	
	Background Accurate models to predict mortality are needed for risk stratification in patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI). 

	Methods and Results We examined 5745 patients with STEMI undergoing primary PCI in the Assessment of Pexelizumab in Acute Myocardial Infarction trial within 6 hours of symptom onset. A Cox proportional hazards model incorporating regression splines to accommodate nonlinearity in...]]></description>
			<author>www.gise.it</author>
			<pubDate>Tue, 12 Oct 2010 12:21:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/479/a_model_for_predicting_mortality_in</guid>		
	</item><item>	
			<title><![CDATA[Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents]]></title>
			<link>http://www.gise.it/news/476/comparison_of_zotarolimus_eluting_a</link>				
			<description><![CDATA[ 

	
		
			
			Original Article
		
			Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents
		
			Patrick W. Serruys, M.D., Ph.D., Sigmund Silber, M.D., Ph.D., Scot Garg, M.B., Ch.B., M.R.C.P., Robert Jan van Geuns, M.D., Ph.D., Gert Richardt, M.D., Pawel E. Buszman, M.D., Ph.D., Henning Kelbæk, M.D., Adrianus Johannes van Boven, M.D., Ph.D., Sjoerd H. Hofma, M.D., Ph.D., Axel Linke, M.D., Ph.D., Volker Klauss, M.D., Ph.D., William Wijns, M.D., Ph.D., Carlos Macaya, M.D., Ph.D...]]></description>
			<author>www.gise.it</author>
			<pubDate>Mon, 04 Oct 2010 18:18:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/476/comparison_of_zotarolimus_eluting_a</guid>		
	</item><item>	
			<title><![CDATA[Lo studio PARTNER presentato al TCT: Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery]]></title>
			<link>http://www.gise.it/news/471/lo_studio_partner_presentato_al_tct</link>				
			<description><![CDATA[ 

	
		
		Background
	
		Many patients with severe aortic stenosis and coexisting conditions are not candidates for surgical replacement of the aortic valve. Recently, transcatheter aortic-valve implantation (TAVI) has been suggested as a less invasive treatment for high-risk patients with aortic stenosis.
	
		Full Text of Background...


	 

	
		Methods
	
		We randomly assigned patients with severe aortic stenosis, whom surgeons considered not to be suitable candidates for surgery, to standard ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Fri, 24 Sep 2010 18:47:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/471/lo_studio_partner_presentato_al_tct</guid>		
	</item><item>	
			<title><![CDATA[ESC Congress 2010]]></title>
			<link>http://www.gise.it/news/54/esc_congress_2010</link>				
			<description><![CDATA[Vai al sito ufficiale del congresso ESC 2010]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 11:03:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/54/esc_congress_2010</guid>		
	</item><item>	
			<title><![CDATA[TCT 2010]]></title>
			<link>http://www.gise.it/news/52/tct_2010</link>				
			<description><![CDATA[Questo è il sito ufficiale TCT 2010]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 10:00:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/52/tct_2010</guid>		
	</item><item>	
			<title><![CDATA[Relationship Between Arterial and Fibrous Cap Remodeling]]></title>
			<link>http://www.gise.it/news/51/relationship_between_arterial_and_f</link>				
			<description><![CDATA[ Background&mdash;Positive arterial remodeling and thin fibrous cap are characteristics of rupture-prone or vulnerable plaque. The natural course of the fibrous cap thickness and the relationship between serial arterial remodeling and changes in fibrous cap thickness are unknown. Therefore, the purpose of this study was to evaluate the relationship between changes in fibrous cap thickness and arterial remodeling by using optical coherence tomography (OCT) and intravascular ultrasound (IVUS) duri...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 09:55:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/51/relationship_between_arterial_and_f</guid>		
	</item><item>	
			<title><![CDATA[While the propensity-matched analysis narrowly missed its primary end point, secondary end points pointed to significant differences in MI rates that tracked with differences in stent thrombosis. ]]></title>
			<link>http://www.gise.it/news/50/while_the_propensity_matched_analys</link>				
			<description><![CDATA[ "Stockholm, Sweden - A nonrandomized comparison of sirolimus-eluting and everolimus-eluting stents is providing some of the strongest evidence yet that so-called "next-generation" drug-eluting stents (DES) may have an edge in terms of safety and efficacy over the first drug-eluting stent on the market. Dr Stephan Windecker (Bern University Hospital, Switzerland) presented the results of LESSON I here during a hot-line session of the European Society of Cardiology 2010 Congress, noting that the ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 09:44:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/50/while_the_propensity_matched_analys</guid>		
	</item><item>	
			<title><![CDATA[Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction: A Contemporary Review and Argument for Percutaneous Coronary Intervention ]]></title>
			<link>http://www.gise.it/news/49/unprotected_left_main_coronary_dise</link>				
			<description><![CDATA[ 

State-of-the-Art Paper

Unprotected Left Main Coronary Disease and ST-Segment Elevation Myocardial Infarction

A Contemporary Review and Argument for Percutaneous Coronary Intervention

Michael S. Lee, MD*,*, Pooya Bokhoor, MD*, Seung-Jung Park, MD, Young-Hak Kim, MD, Gregg W. Stone, MD, Imad Sheiban, MD, Giuseppe Biondi-Zoccai, MD, Dario Sillano, MD, Jonathan Tobis, MD*, David E. Kandzari, MD||


* Reprint requests and correspondence: Dr. Michael S. Lee, UCLA Medical Center, Adult Cardiac Ca...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 09:40:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/49/unprotected_left_main_coronary_dise</guid>		
	</item><item>	
			<title><![CDATA[Effects of CYP2C19 Genotype on Outcomes of Clopidogrel Treatment]]></title>
			<link>http://www.gise.it/news/48/effects_of_cyp2c19_genotype_on_outc</link>				
			<description><![CDATA[ These investigators found that in patients with acute coronary syndromes or atrial fibrillation, the effect of clopidogrel was consistent, irrespective of CYP2C19 genotype. An increased benefit of clopidogrel was observed in some carriers of gain-of-function alleles.

]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 09:39:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/48/effects_of_cyp2c19_genotype_on_outc</guid>		
	</item><item>	
			<title><![CDATA[The Stent for Life Initiative (SFL) Celebrates its First Year Anniversary as the ESC 2010 Congress in Stockholm]]></title>
			<link>http://www.gise.it/news/47/the_stent_for_life_initiative_sfl_c</link>				
			<description><![CDATA[InspireMD Ltd., a medical device company engaged in the development and commercialization of MGuard(TM) novel stent systems, is happy to announce that it has joined the Stent for Life Initiative as a supporting organization. The Stent for Life Initiative aims to improve the delivery and patient access to the life saving indications of PCI and thereby reduce the mortality and morbidity of patients suffering from acute coronary syndromes.
InspireMD, Ltd., is a medical device company, that engages ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 01 Sep 2010 09:38:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/47/the_stent_for_life_initiative_sfl_c</guid>		
	</item><item>	
			<title><![CDATA[Evacs 2010]]></title>
			<link>http://www.gise.it/news/15/evacs_2010</link>				
			<description><![CDATA[Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed quis neque ut est pulvinar porta in vel tortor. Mauris feugiat gravida dictum. In tortor nulla, blandit malesuada dapibus et, ultricies eget nulla. Nam dapibus, dui nec euismod pharetra, arcu mi porttitor nulla, ac commodo arcu turpis eu lectus. Aliquam et porta lectus. Proin ornare cursus diam ut adipiscing. Duis ac mi eros. Nunc in nisi a dui rhoncus volutpat. Nulla est elit, tempor eget blandit vel, tincidunt eget mi. Duis lorem leo...]]></description>
			<author>www.gise.it</author>
			<pubDate>Wed, 25 Aug 2010 17:04:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/15/evacs_2010</guid>		
	</item><item>	
			<title><![CDATA[Close the Gap - Helping to save and improve lives ]]></title>
			<link>http://www.gise.it/news/16/close_the_gap_helping_to_save_and_i</link>				
			<description><![CDATA[Did you know that:
Every 38 seconds an American dies of heart disease?1
Heart disease is the #1 Killer in the United States?1
Heart disease causes more deaths in Americans of both genders and all racial and ethnic groups than any
other disease?2
In 2006, a team of physicians and other health care professionals from across the United States came together through the Close the Gap initiative to identify opportunities and develop strategies to address disparities in cardiovascular care for the unde...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 29 Jul 2010 11:35:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/16/close_the_gap_helping_to_save_and_i</guid>		
	</item><item>	
			<title><![CDATA[EAPCI]]></title>
			<link>http://www.gise.it/news/11/eapci</link>				
			<description><![CDATA[Our mission: To reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 29 Jul 2010 11:32:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/11/eapci</guid>		
	</item><item>	
			<title><![CDATA[The ARTS II]]></title>
			<link>http://www.gise.it/news/10/the_arts_ii</link>				
			<description><![CDATA[
]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 29 Jul 2010 10:42:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/10/the_arts_ii</guid>		
	</item><item>	
			<title><![CDATA[ TAVI: Canadian Multicenter Experience]]></title>
			<link>http://www.gise.it/news/9/_tavi_canadian_multicenter_experien</link>				
			<description><![CDATA[Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical Risk

Acute and Late Outcomes of the Multicenter Canadian ExperienceObjectives: The aim of this study was: 1) to evaluate the acute and late outcomes of a transcatheter aortic valve implantation (TAVI) program including both the transfemoral (TF) and transapical (TA) approaches; and 2) to determine the results of TAVI in patients deemed inoperable becau...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 29 Jul 2010 10:41:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/9/_tavi_canadian_multicenter_experien</guid>		
	</item><item>	
			<title><![CDATA[Valutazione delle biforcazioni]]></title>
			<link>http://www.gise.it/news/8/valutazione_delle_biforcazioni</link>				
			<description><![CDATA[Anatomic and Functional Evaluation of Bifurcation Lesions Undergoing Percutaneous Coronary Intervention

Bon-Kwon Koo, MD, PhD; Katsuhisa Waseda, MD, PhD; Hyun-Jae Kang, MD, PhD; Hyo-Soo Kim, MD, PhD; Chang-Wook Nam, MD, PhD; Seung-Ho Hur, MD, PhD; Jung-Sun Kim, MD, PhD; Donghoon Choi, MD, PhD; Yangsoo Jang, MD, PhD; Joo-Yong Hahn, MD, PhD; Hyeon-Cheol Gwon, MD, PhD; Myeong-Ho Yoon, MD, PhD; Seung-Jea Tahk, MD, PhD; Woo-Young Chung, MD, PhD; Young-Seok Cho, MD, PhD; Dong-Ju Choi, MD, PhD; Takao ...]]></description>
			<author>www.gise.it</author>
			<pubDate>Thu, 29 Jul 2010 10:40:00 +0200</pubDate>
			<category>Home</category>				
			<guid isPermaLink="true">http://www.gise.it/news/8/valutazione_delle_biforcazioni</guid>		
	</item> </channel>
</rss>
